The colorimetric analysis of anti-tuberculosis fixed-dose combination tablets and capsules

International Journal of Tuberculosis and Lung Disease

Volumn 3, Issue 11 SUPPL. 3, 1999, Pages

  Ellard, G A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Colorimetric drug analysis; Ethambutol; Isoniazid; Pyrazinamide; Rifampicin

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

CALORIMETRY; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DETERMINATION; DRUG FORMULATION; DRUG URINE LEVEL; HUMAN; PRIORITY JOURNAL; TABLET;

ANTITUBERCULAR AGENTS; CAPSULES; CHEMISTRY, PHARMACEUTICAL; COLORIMETRY; DRUG COMBINATIONS; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPIN; TABLETS;

EID: 0032737914     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Pillai G, Fourie P B, Padayatchi N, et al. Recent bioequivalence studies on fixed-dose combination anti-tuberculosis drug formulations available on the global market. Int J Tuberc Lung Dis 1999; 3 (Suppl 3): S309-S316.
2. Catalani E. Review of the Indian market of anti-tuberculosis drugs: focus on the utilisation of rifampicin-based products. Int J Tuberc Lung Dis 1999; 3 (Suppl 3): S289-S291.
3. Pelizza G, Nebuloni M, Ferrari P, Gallo G G. Polymorphism of rifampicin. Il Farmaco (Edizione Scientifica) 1977; 32: 471-481.
4. Sunahara S, Nakagawa H. Metabolic study and controlled clinical trials of rifampin. Chest 1972; 61: 526-532.
5. Ellard G A, Gammon P T, Wallace S M. The determination of isoniazid and its metabolites acetylisoniazid, monoacetylhydrazine, diacetylhydrazine, isonicotinic acid and isonicotinylglycine in serum and urine. Biochem J 1972; 126: 449-458.
6. Ellard G A. Absorption, metabolism and excretion of pyrazinamide in man. Tubercle 1969; 50: 144-158.
7. Fröseth B. Preliminary report on a modified method for determination of ethambutol in serum. Scand J Respir Dis 1970; 69 (Suppl): 81.
8. Maher J R, Whitney J M, Chambers J S, Stononis D J. The quantitative determination of isoniazid and para-aminosalicylic acid in body fluids. Am Rev Tuberc 1957; 76: 852-861.
9. Caccia P A. Spectrophotometric determination of pyrazinamide blood concentrations and excretion through the kidneys. Am Rev Tuberc 1957; 75: 105-110.
10. Ellard G A, Gammon P T. Pharmacokinetics of isoniazid metabolism in man. J Pharmacokin Biopharm 1976; 4: 83-113.
11. Ellard G A, Ellard D R, Allen B W, et al. The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis. Am Rev Respir Dis 1986; 133: 1076-1080.
12. Smith P J, van Dyk J, Fredericks A. Determination of rifampicin, isoniazid and pyrazinamide by high performance liquid chromatography after their simultaneous extraction from plasma. Int J Tuberc Lung Dis 1999; 3 (Suppl 3): S325-S329.
13. British Pharmacopoeia. 1998.
14. Kenyon T A, Kenyon A S, Kgarebe B V, Mothibedi D, Binkin N J, Layloff T P. Detection of substandard fixed-dose combination tuberculosis drugs using thin-layer chromatography. Int J Tuberc Lung Dis 1999; 3 (Suppl 3): S347-S350.